Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Telangana govt seeks Centre’s approval for Rs 38,595-crore Hyderabad Metro Phase-II project
Telangana government seeks Union government approval for the ₹38,595 crore Hyderabad Metro Rail Phase-II project. Chief Minister Revanth Reddy met Union Minister Manohar Lal Khattar to expedite approvals. The state aims for a joint venture for the 122.9 km expansion. Hyderabad's rapid growth necessitates this urban transport network enhancement.
Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing
Five stocks from the Nifty500 universe were flagged in the RSI Trending Up scan on May 4 after gaining over 4%. The indicator turned positive as RSI crossed above 50 from lower levels, signalling improving momentum, strengthening sentiment, and potential short-term buying opportunities in select stocks.
Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results — Here's Why
Dr. Lal's management anticipates strong momentum in the Delhi NCR market and better traction in Suburban Diagnostics to translate into 13-15% revenue growth for FY27.
Here's why these two healthcare stocks are surging up to 10% on Monday
Healthcare stocks are in focus today, with shares of Dr Lal PathLabs and Aster DM Healthcare rallying after their March quarter earnings and upbeat brokerage commentary.
Q4 Results LIVE Updates: Sundram Fasteners profit up 30%; ESAF SFB NII grows 20%
Q4 Results LIVE Updates: Today is the busiest day in terms of quarterly results this week. The big earnings reaction of the day comes from Bajaj Finance where brokerages have raised their targets and even upgraded the stock, along with Waaree Energies, who also issued its guidance for FY27. The biggest result of the day comes from Hindustan Unilever (HUL), followed by Adani twins on the Nifty (Ports & Enterprises), Bajaj Finserv, ACC, Laurus Labs, Dr. Lal Pathlabs, RailTel, Newgen Software and others. Follow for all the Live updates.
Dr Lal Pathlabs consolidated net profit declines 15.18% in the March 2026 quarter
Sales rise 16.61% to Rs 702.70 crore
Dr Lal PathLabs Q4 Results: Profit slips 15% despite strong revenue growth; ₹4 dividend announced
Dr Lal PathLabs Q4: net profit down 15.2 percent to 131.3 crore, revenue up 16.6 percent to 702.7 crore, margins narrow, board proposes 4 rupee final dividend per share
India ready to meet 270 GW peak power demand this summer, says Manohar Lal
India is ready for this summer's peak power demand of 270 GW. The nation's power infrastructure is robust. Future demand will rise with AI, data centers, and electric vehicles. Transmission lines are expanding significantly. This ensures reliable power supply for growing needs.
Lorenzini Apparels Ltd leads losers in 'B' group
SEPC Ltd, Archidply Decor Ltd, Panorama Studios International Ltd and MRC Agrotech Ltd are among the other losers in the BSE's 'B' group today, 13 March 2026.
Bloomin’ Brands director Lal Rohit buys $56,900 in stock - Investing.com India
Bloomin’ Brands director Lal Rohit buys $56,900 in stockInvesting.com India
NTPC pays power ministry Rs 2,666.58 cr in second dividend for FY26
A ceremonial cheque was handed over to Minister of Power Manohar Lal by company officials on February 27, NTPC said in a statement.
Dr Lal PathLabs surges 9% as it forays into Dubai market with new subsidiary
The stock rose as much as 9.43% to Rs 1,768.40 in morning trade.